TWF2

TWF2 (twinfilin-2) is an evolutionarily conserved ADF-H domain actin-regulatory protein that binds actin monomers, caps actin filament barbed ends, and dynamically remodels actin networks (PMID:18837697). The mouse gene produces two biochemically distinct isoforms by alternative promoter usage—TWF2a, broadly expressed in non-muscle tissues, binds ADP- and ATP-G-actin with equal affinity, whereas the muscle-restricted TWF2b binds ADP-G-actin with ~5-fold higher affinity—but both isoforms cap barbed ends and bind capping protein (PMID:18837697). Beyond static capping, TWF2 actively promotes barbed-end depolymerization and rapidly displaces (uncaps) capping protein from filament ends, and through this activity regulates F-actin levels and actomyosin contractility, as established by C. elegans genetics where loss of the ortholog suppresses both capping-protein-depletion lethality and hypercontractility downstream of spectrin scaffolding (PMID:41195540, PMID:40667244). In vertebrate hair cells, TWF2 co-localizes with the CAPZB capping-protein subunit at row 2 stereocilia tips, where its enrichment depends on functional mechanotransduction and contributes, as part of a complex that also includes BAIAP2L2 and EPS8L2, to specifying stereocilia dimensions (PMID:28899994, PMID:31902726, PMID:34346063). TWF2 is a substrate of PKCzeta, casein kinase 2, and most effectively Src, linking it to kinase signaling (PMID:10406962). In renal cell carcinoma, TWF2 acquires a signaling role by binding YAP (via TWF2 residue M99 and YAP M225) and competitively displacing LATS1, thereby blocking YAP ubiquitination, stabilizing nuclear YAP, suppressing Hippo signaling, and driving invasion, metastasis, and sunitinib resistance (PMID:40948085).

1. 1999 Medium

   Before its actin role was defined, TWF2 was placed in a kinase-signaling context by identifying it as a phosphorylation target, establishing that it is regulated by serine/threonine and tyrosine kinases.

   Evidence Yeast two-hybrid against PKCzeta plus in vitro kinase assays with GST fusions and an ATP-binding assay

   PMID:10406962

   Open questions at the time

   • Functional consequence of phosphorylation on actin binding or capping not tested
   • Phosphosites not mapped
   • No cellular validation of the PKCzeta interaction
2. 2009 High

   Resolved whether TWF2 is a single biochemical entity by showing two promoter-driven isoforms with distinct nucleotide-state actin preferences and tissue distributions, establishing TWF2 as a tissue-specialized actin monomer-binding and barbed-end capping protein.

   Evidence Alternative promoter identification with in vitro actin monomer binding, capping, and ADP/ATP-G-actin affinity measurements

   PMID:18837697

   Open questions at the time

   • Functional difference between isoforms in cells not demonstrated
   • Physiological role of muscle-restricted TWF2b not addressed
3. 2017 High

   Connected TWF2 to a defined cellular structure by showing it co-localizes with CAPZB at stereocilia tips and that capping protein controls stereocilia width, placing TWF2 in the actin machinery that sizes mechanosensory protrusions.

   Evidence Immunofluorescence, conditional Capzb knockout, and CAPZB2 electroporation in mouse hair cells

   PMID:28899994

   Open questions at the time

   • Direct functional requirement for TWF2 (vs CAPZB) in stereocilia not isolated
   • Whether TWF2 caps or uncaps in this context unresolved
4. 2020 High

   Established that TWF2 tip localization is not constitutive but is specified by mechanotransduction, defining it as a member of an activity-dependent row 2 protein complex.

   Evidence Quantitative immunofluorescence of cochleas from Tmc1/Tmc2 and Tmie transduction mutants

   PMID:31902726

   Open questions at the time

   • Molecular signal coupling channel activity to TWF2 recruitment unknown
   • TWF2 loss-of-function phenotype in hair cells not shown
5. 2021 Medium

   Identified BAIAP2L2 as a binding partner that organizes the row 2 complex containing TWF2, EPS8L2, and CAPZB2, defining the protein interaction architecture maintaining mechanotransducing stereocilia.

   Evidence Co-immunoprecipitation and Baiap2l2 knockout mice with electrophysiology and FM dye uptake

   PMID:34346063

   Open questions at the time

   • Direct vs indirect nature of BAIAP2L2-TWF2 binding not resolved
   • Whether TWF2 is required for complex integrity untested
6. 2025 High

   Resolved the mechanistic basis of TWF2's actin-remodeling activity in vivo by showing it depolymerizes barbed ends, uncaps capping protein, and regulates tissue contractility via spectrin-anchored localization.

   Evidence C. elegans genetic epistasis with cap-1 and spv-1, in vitro depolymerization/uncapping assays, and Co-IP with α/β-spectrin

   PMID:40667244 PMID:41195540

   Open questions at the time

   • Whether vertebrate TWF2 uncaps CAPZB in stereocilia not directly tested
   • Isoform specificity of uncapping activity not addressed
7. 2025 Medium

   Revealed a non-cytoskeletal signaling role by showing TWF2 binds YAP and displaces LATS1 to stabilize YAP, linking TWF2 to Hippo pathway suppression and cancer progression.

   Evidence Co-IP, M99/M225 site-directed mutagenesis, invasion/migration assays, PDX models, and a small-molecule inhibitor of the TWF2-YAP interaction

   PMID:40948085

   Open questions at the time

   • Relationship between actin-regulatory and YAP-binding functions of TWF2 unknown
   • Whether the interaction generalizes beyond renal cell carcinoma not established
   • Structural basis of M99-M225 contact not defined

• How TWF2's biochemical activities (capping vs uncapping/depolymerization), its kinase regulation, and its YAP-binding signaling function are integrated within a single protein across tissues remains unresolved.
• No structural model linking the actin-binding and YAP-binding surfaces
• Whether phosphorylation by PKCzeta/Src switches between capping and signaling roles untested
• Isoform-specific functions in mammalian tissues uncharacterized